Skip to main content

Table 1 Treatment of distant metastatic tumors with MAGE-1-modified DC vaccines

From: CCL3 and CCL20-recruited dendritic cells modified by melanoma antigen gene-1 induce anti-tumor immunity against gastric cancer ex vivo and in vivo

Treatment Number of Lung metastases
DC-Ad-MAGE-1 *31.38 ± 2.26
DC-Ad-LacZ 120.75 ± 2.71
DC-MFC Ag 77.25 ± 3.37
Untreated DC 124.38 ± 3.58
  1. * P < 0.05, DC-Ad-MAGE-1 versus the other control groups.